Document is current
Any future updates will be listed below
-
Authors
Gobbi, Carlotta
Sánchez-Marín, Laura
Flores-López, María
Medina-Vera, Dina
Pavón-Morón, Francisco Javier
Rodríguez de Fonseca, Fernando
Serrano, Antonia
-
Funding
Funding for this research was provided by:
Instituto de Salud Carlos III (ISCIII), Ministerio de Ciencia e Innovación and European Regional Development Funds-European Union (PI19/00886, PI20/01399, PI22/00427 and PI22/01833, PI19/00886, PI20/01399, PI22/00427 and PI22/01833, PI19/00886, PI20/01399, PI22/00427 and PI22/01833)
Plataforma de biobanco y biomodelos animales y 3D de Málaga (PT20-00101, PT20-00101)
Programa RICORS RIAPAD (RD21/0009/0003, RD21/0009/0003)
Ministerio de Sanidad, Delegación de Gobierno para el Plan Nacional sobre Drogas (PNSD 2022/020)
- License Information
-
More Information
Article History
Received: 12 June 2024
Accepted: 9 September 2024
First Online: 26 September 2024
Declarations
:
: involving human participants, human data or human tissue are not applicable. This manuscript involves the use of animal data and tissue. All animal procedures were conducted in strict adherence to ARRIVE guidelines and the principles of laboratory animal care (National Research Council, Neuroscience CoGftUoAi, Research B, 2003) following the European Community Council Directive (63/2010/UE) and the Spanish Directive (RD52/2013). All animal procedures were approved by the Ethical Committee of the University of Málaga (Exp. Nº: 67-2020-A).
: Not applicable.
: The authors declare no competing interests.
: The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.
